NCT01742468 Intervention With Long-chain n-3 Polyunsaturated Fatty Acids From Microalgae Oil in Patients With Rheumatoid Arthritis Status COMPLETED Phase NA
NCT01741688 An Observational Study of Tocilizumab (Actemra) in Participants With Moderate to Severe Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT01741493 A Study in Healthy Adults and Adult Subjects With Rheumatoid Arthritis to Evaluate the Safety, Tolerability and Pharmacokinetics After Multiple Doses of ABT-494 Status COMPLETED Phase PHASE1
NCT01737944 Exposure Study Comparing 3 Routes of Methotrexate (MTX) Administration Status COMPLETED Phase PHASE1/PHASE2
NCT01736189 Assessment of Clinical Effectiveness and Safety of Adalimumab and High Dose Methotrexate in Routine Clinical Practice Status COMPLETED Phase N/A
NCT01734993 A Long-Term Extension Study of WA22762 to Evaluate Safety and Efficacy of Subcutaneous Tocilizumab in Participants With Moderate to Severe Rheumatoid Arthritis (RA). Status COMPLETED Phase PHASE3
NCT01730456 A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Early Moderate to Severe Rheumatoid Arthritis Who Completed Study WA19926 Status COMPLETED Phase PHASE3
NCT01725230 Assess the Pharmacokinetics of Rosuvastatin and Simvastatin When Administered Alone or in Combination With Fostamatinib Status COMPLETED Phase PHASE1
NCT01724931 Aminopterin Dose Finding Treatment for Methotrexate-Naïve Rheumatoid Arthritis Status COMPLETED Phase PHASE2
NCT01724268 Corticosteroids and Anti TNF in Methotrexate Inadequate Responder Rheumatoid Arthritis Patient Status UNKNOWN Phase PHASE3
NCT01721057 A Study in Moderate to Severe Rheumatoid Arthritis Participants Status COMPLETED Phase PHASE3
NCT01717859 Musculoskeletal Ultrasound in Predicting Early Dose Titration With Tocilizumab Status COMPLETED Phase PHASE4
NCT01717846 Effect on Orencia (Abatacept) on the Apoptosis of T Cells, B Cells and APC Cells in Rheumatoid Arthritis Status WITHDRAWN Phase PHASE4
NCT01715896 A Study of Mavrilimumab Versus Anti Tumor Necrosis Factor in Subjects With Rheumatoid Arthritis Status COMPLETED Phase PHASE2
NCT01712399 A Long Term Safety Study of Mavrilimumab in Adult Subjects With Rheumatoid Arthritis Status TERMINATED Phase PHASE2